ChemPartner PharmaTech Co.,Ltd. (SHE:300149)

ChemPartner PharmaTech Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	367.9	368.33	347.26	761.66	160.46	259.12
Trading Asset Securities	34.09	1.05	2.21	-	18.98	20.08
Cash & Short-Term Investments	401.99	369.37	349.47	761.66	179.44	279.2
Cash Growth	24.93%	5.70%	-54.12%	324.46%	-35.73%	5.18%
Accounts Receivable	203.81	199.01	268.11	349.87	372.28	423.16
Other Receivables	37.36	12.06	12.01	87.18	8.49	86.26
Receivables	241.17	211.07	280.12	437.06	380.77	509.41
Inventory	9.19	11.44	27.88	42.82	68.81	54.81
Prepaid Expenses	-	0.87	11.03	-	-	-
Other Current Assets	45.11	51.31	58.68	38.82	58.72	76.46
Total Current Assets	697.46	644.07	727.18	1,280	687.74	919.88
Property, Plant & Equipment	636.61	683.88	851.39	973.62	1,512	946.13
Long-Term Investments	176.12	214.46	199.79	197.02	175.96	153.24
Goodwill	-	-	139.26	858.86	1,207	1,575
Other Intangible Assets	34.22	30.66	30.05	55.66	148.61	165
Long-Term Deferred Tax Assets	41.15	39.46	40.45	10.66	4.89	13.1
Long-Term Deferred Charges	245	267.09	324.36	370.23	385.02	281.79
Other Long-Term Assets	158.89	116.18	121.85	77.49	96.39	67.38
Total Assets	1,989	1,996	2,434	3,824	4,218	4,122
Accounts Payable	48.69	64.02	53.79	80.7	108.38	80.17
Accrued Expenses	40.49	58.19	82.78	100.26	90.66	108.68
Short-Term Debt	50.31	58.47	60	115.02	158.57	112.5
Current Portion of Long-Term Debt	69.39	6.52	4.3	111.47	330.13	228.9
Current Portion of Leases	-	73.98	69.63	67.24	72.83	5.93
Current Income Taxes Payable	6.41	4.61	5.42	49.85	8.6	4.58
Current Unearned Revenue	42.37	41.93	77.21	78.26	57.59	64.11
Other Current Liabilities	75.08	38.97	73.63	129.24	163.91	182.73
Total Current Liabilities	332.73	346.7	426.77	732.03	990.66	787.6
Long-Term Debt	33.01	37.2	43.67	177.21	614.92	792.13
Long-Term Leases	311.96	337.13	457.73	495.25	570.58	2.86
Long-Term Unearned Revenue	24.89	28.36	27.43	16.41	20.47	22.55
Long-Term Deferred Tax Liabilities	3.38	2.88	12.58	12.01	26.07	33.44
Other Long-Term Liabilities	5.65	5.47	5.24	5.02	5.81	30.62
Total Liabilities	711.62	757.75	973.44	1,438	2,229	1,669
Common Stock	497.96	497.96	499.78	499.78	499.78	499.78
Additional Paid-In Capital	1,240	1,205	1,229	1,229	1,229	1,229
Retained Earnings	-503.83	-510.92	-284.45	648.27	269.68	706.91
Treasury Stock	-	-	-25.51	-25.51	-20.44	-
Comprehensive Income & Other	19.05	21.33	17.64	9.81	-13.76	-7.97
Total Common Equity	1,254	1,214	1,437	2,362	1,964	2,428
Minority Interest	24.27	24.2	24.24	24.43	24.63	24.48
Shareholders' Equity	1,278	1,238	1,461	2,386	1,989	2,452
Total Liabilities & Equity	1,989	1,996	2,434	3,824	4,218	4,122
Total Debt	464.67	513.31	635.34	966.2	1,747	1,142
Net Cash (Debt)	-62.68	-143.93	-285.88	-204.53	-1,568	-863.12
Net Cash Per Share	-0.13	-0.29	-0.57	-0.41	-3.16	-1.73
Filing Date Shares Outstanding	502.79	497.96	497.96	497.96	498.33	498.33
Total Common Shares Outstanding	502.79	497.96	497.96	497.96	498.33	499.78
Working Capital	364.73	297.37	300.4	548.33	-302.91	132.28
Book Value Per Share	2.49	2.44	2.89	4.74	3.94	4.86
Tangible Book Value	1,219	1,183	1,267	1,447	608.37	687.84
Tangible Book Value Per Share	2.43	2.38	2.55	2.91	1.22	1.38
Buildings	-	102.02	103.1	52.82	238.54	239.42
Machinery	-	533.18	554.12	464.19	791.09	693.18
Construction In Progress	-	13	7.96	75.36	235.74	308.78

Source: S&P Global Market Intelligence. Standard template. Financial Sources.